Clinical Trial Update: Methylene Blue in Sepsis: A Randomized Controlled Trial [NA]

View source ↗

Summary

A randomized controlled trial evaluating methylene blue for sepsis has been withdrawn. This update confirms the study status as withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: Queen's University | Conditions: Sepsis | NA | Status: WITHDRAWN